193 related articles for article (PubMed ID: 20407034)
1. Pegylated arginase I: a potential therapeutic approach in T-ALL.
Hernandez CP; Morrow K; Lopez-Barcons LA; Zabaleta J; Sierra R; Velasco C; Cole J; Rodriguez PC
Blood; 2010 Jun; 115(25):5214-21. PubMed ID: 20407034
[TBL] [Abstract][Full Text] [Related]
2. Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia.
Morrow K; Hernandez CP; Raber P; Del Valle L; Wilk AM; Majumdar S; Wyczechowska D; Reiss K; Rodriguez PC
Leukemia; 2013 Mar; 27(3):569-77. PubMed ID: 22926702
[TBL] [Abstract][Full Text] [Related]
3. The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated-recombinant arginase I BCT-100.
De Santo C; Booth S; Vardon A; Cousins A; Tubb V; Perry T; Noyvert B; Beggs A; Ng M; Halsey C; Kearns P; Cheng P; Mussai F
Int J Cancer; 2018 Apr; 142(7):1490-1502. PubMed ID: 29168171
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest.
Lam TL; Wong GK; Chong HC; Cheng PN; Choi SC; Chow TL; Kwok SY; Poon RT; Wheatley DN; Lo WH; Leung YC
Cancer Lett; 2009 May; 277(1):91-100. PubMed ID: 19138817
[TBL] [Abstract][Full Text] [Related]
5. l-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells.
Fletcher M; Ramirez ME; Sierra RA; Raber P; Thevenot P; Al-Khami AA; Sanchez-Pino D; Hernandez C; Wyczechowska DD; Ochoa AC; Rodriguez PC
Cancer Res; 2015 Jan; 75(2):275-83. PubMed ID: 25406192
[TBL] [Abstract][Full Text] [Related]
6. Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts.
Lam SK; Li YY; Xu S; Leung LL; U KP; Zheng YF; Cheng PN; Ho JC
Respir Res; 2017 May; 18(1):80. PubMed ID: 28464918
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human arginase induces apoptosis through oxidative stress and cell cycle arrest in small cell lung cancer.
Xu S; Lam SK; Cheng PN; Ho JC
Cancer Sci; 2018 Nov; 109(11):3471-3482. PubMed ID: 30155941
[TBL] [Abstract][Full Text] [Related]
8. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion.
Cheng PN; Lam TL; Lam WM; Tsui SM; Cheng AW; Lo WH; Leung YC
Cancer Res; 2007 Jan; 67(1):309-17. PubMed ID: 17210712
[TBL] [Abstract][Full Text] [Related]
9. Arginine deprivation in cancer therapy.
Feun LG; Kuo MT; Savaraj N
Curr Opin Clin Nutr Metab Care; 2015 Jan; 18(1):78-82. PubMed ID: 25474015
[TBL] [Abstract][Full Text] [Related]
10. Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo.
Miraki-Moud F; Ghazaly E; Ariza-McNaughton L; Hodby KA; Clear A; Anjos-Afonso F; Liapis K; Grantham M; Sohrabi F; Cavenagh J; Bomalaski JS; Gribben JG; Szlosarek PW; Bonnet D; Taussig DC
Blood; 2015 Jun; 125(26):4060-8. PubMed ID: 25896651
[TBL] [Abstract][Full Text] [Related]
11. 3,3'-Diindolylmethane induces G1 arrest and apoptosis in human acute T-cell lymphoblastic leukemia cells.
Shorey LE; Hagman AM; Williams DE; Ho E; Dashwood RH; Benninghoff AD
PLoS One; 2012; 7(4):e34975. PubMed ID: 22514694
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis.
Lam TL; Wong GK; Chow HY; Chong HC; Chow TL; Kwok SY; Cheng PN; Wheatley DN; Lo WH; Leung YC
Pigment Cell Melanoma Res; 2011 Apr; 24(2):366-76. PubMed ID: 21029397
[TBL] [Abstract][Full Text] [Related]
13. Rational design, engineer, and characterization of a novel pegylated single isomer human arginase for arginine depriving anti-cancer treatment.
Yu KM; Pang TP; Cutler M; Tian M; Huang L; Lau JY; Chung SF; Lo TW; Leung TY
Life Sci; 2021 Jan; 264():118674. PubMed ID: 33129876
[TBL] [Abstract][Full Text] [Related]
14. L-arginine availability regulates T-lymphocyte cell-cycle progression.
Rodriguez PC; Quiceno DG; Ochoa AC
Blood; 2007 Feb; 109(4):1568-73. PubMed ID: 17023580
[TBL] [Abstract][Full Text] [Related]
15. Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation.
Wells JW; Evans CH; Scott MC; Rütgen BC; O'Brien TD; Modiano JF; Cvetkovic G; Tepic S
PLoS One; 2013; 8(1):e54464. PubMed ID: 23365669
[TBL] [Abstract][Full Text] [Related]
16. Human Recombinant Arginase I [HuArgI (Co)-PEG5000]-Induced Arginine Depletion Inhibits Colorectal Cancer Cell Migration and Invasion.
Al-Koussa H; Al-Haddad M; Abi-Habib R; El-Sibai M
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795337
[TBL] [Abstract][Full Text] [Related]
17. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
[TBL] [Abstract][Full Text] [Related]
18. ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia.
Peirs S; Matthijssens F; Goossens S; Van de Walle I; Ruggero K; de Bock CE; Degryse S; Canté-Barrett K; Briot D; Clappier E; Lammens T; De Moerloose B; Benoit Y; Poppe B; Meijerink JP; Cools J; Soulier J; Rabbitts TH; Taghon T; Speleman F; Van Vlierberghe P
Blood; 2014 Dec; 124(25):3738-47. PubMed ID: 25301704
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of cell death induced by arginase and asparaginase in precursor B-cell lymphoblasts.
Métayer LE; Brown RD; Carlebur S; Burke GAA; Brown GC
Apoptosis; 2019 Feb; 24(1-2):145-156. PubMed ID: 30578463
[TBL] [Abstract][Full Text] [Related]
20. Preclinical safety and antitumor activity of the arginine-degrading therapeutic enzyme pegzilarginase, a PEGylated, cobalt-substituted recombinant human arginase 1.
Agnello G; Alters SE; Rowlinson SW
Transl Res; 2020 Mar; 217():11-22. PubMed ID: 31954097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]